RF34 | PMON276 The Effect of Gender Affirming Hormone Therapy (GAHT) on Non-Conventional Cardiovascular Risk Markers in Transgender Men: A Systematic Review

The process of gender transitioning includes the employment of gender-affirming hormone therapy (GAHT) to attenuate gender dysphoria. Although considered relatively safe, there is still debate whether GAHT may increase the risk of cardiovascular disease (CVD) in transgender men (TM). Non-conventiona...

Descripción completa

Detalles Bibliográficos
Autores principales: Moreira Allgayer, Roberta Martins Costa, Gustavo, da Silva Borba, Ramos, Ramon Bossardi, Filho, Ruy Silveira Moraes, Mara Spritzer, Poli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Reproductive Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625645/
http://dx.doi.org/10.1210/jendso/bvac150.1478

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625645/
http://dx.doi.org/10.1210/jendso/bvac150.1478

Ejemplares similares